Filter
1239
Filtered Results: 1239
Text search:
U.S.
Food
and
Drug
Administration
Featured
Recommendations
118
New Publications
352
Language
Document type
No document type
744
Guidelines
181
Studies & Reports
180
Manuals
60
Strategic & Response Plan
35
Fact sheets
14
Training Material
12
Situation Updates
6
Brochures
2
Resource Platforms
2
Videos
2
Infographics
1
Countries / Regions
India
62
Kenya
38
Global
38
Ethiopia
37
Nigeria
32
Uganda
28
Tanzania
28
South Africa
27
Sierra Leone
25
Liberia
25
Western and Central Europe
24
Philippines
22
Myanmar / Burma
21
Rwanda
19
Zambia
18
Ghana
15
USA
13
Latin America and the Carribbean
12
Nepal
11
Cambodia
11
Indonesia
11
Bangladesh
11
Africa
10
South Sudan
9
Malawi
9
Lesotho
9
Eastern Europe
9
Russia
9
Congo, Democratic Republic of
8
Botswana
8
Zimbabwe
7
Germany
7
Namibia
7
Ukraine
7
Colombia
7
West and Central Africa
7
Middle East and North Africa
6
Haiti
5
Syria
5
Mozambique
5
Brazil
5
Eastern Europe and Central Asia
5
Cameroon
4
Thailand
4
Sudan
4
Eswatini/ Swaziland
4
East and Southern Africa
4
South–East Asia Region
4
Laos
4
Jordan
3
Argentina
3
Peru
3
Paraguay
3
Venezuela
3
Senegal
2
Somalia
2
Iraq
2
Central African Republic
2
Angola
2
Sri Lanka
2
Western Pacific Region
2
Asia
2
Tajikistan
2
Vietnam
2
Guinea
1
Mali
1
Guinea-Bissau
1
Pakistan
1
Afghanistan
1
Turkey
1
Singapore
1
Papua New Guinea
1
Benin
1
Switzerland
1
El Salvador
1
Libya
1
Mexico
1
Yemen
1
Palestine
1
Qatar
1
Lithuania
1
Iran
1
Turkmenistan
1
Denmark
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
491
Clinical Guidelines
135
Public Health
60
Women & Child Health
39
Key Resources
28
Pharmacy & Technologies
18
Capacity Building
12
Toolboxes
Mental Health
107
TB
92
AMR
89
HIV
88
COVID-19
86
Pharmacy
60
Rapid Response
34
Ebola
33
NTDs
30
Caregiver
28
NCDs
26
Planetary Health
23
Refugee
18
Conflict
13
Specific Hazards
13
Disability
11
Zika
8
Global Health Education
8
Cholera
6
Natural Hazards
6
Polio
4
Social Ethics
4
Health Financing Toolbox
3
Health Financing
1
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools ... mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-use research.
The framework adopts the One health approach and focuses on the role that responsible life sciences research can play in preventing and mitigating risks caused by accidents, inadvertent or deliberate misuse with the intention to cause harm to humans, nonhuman animals, plants and agriculture, and the environment.
The "Stories from the field" document by the WHO Regional Office for the Eastern Mediterranean shares effective strategies from the Eastern Mediterranean Region for addressing noncommunicable diseases (NCDs) and mental health challenges, particularl...
To support countries in adapting their response to different COVID-19 scenarios, the World Health
Organization (WHO) Department of Maternal, Newborn, Child and Adolescent Health and Ageing commissi...
The threat posed by Zika virus infection highlights the need to reinforce preparedness arrangements for mosquito-borne diseases in EU/EEA countries, especially for pathogens transmitted by Aedes aegypti and Aedes albopictus.
The aim of this documen...
Standard Treatment Guideline
In this report, we describe early childhood trauma and its effects, offer promising strategies for ECE programs and systems to help young children who have experienced trauma, ... present recommendations for state policymakers and other stakeholders looking to support trauma-informed ECE for this vulnerable group.
Hypertension is the number one health related risk factor in India, with the largest contribution to burden of disease and mortality. It contributes to an estimated 1.6 million deaths, due to ischemic heart disease ... stroke, out of a total of about 10 million deaths annually in India. Fifty seven percent of deaths related to stroke and 24% of deaths related to coronary heart disease are related to hypertension. Hypertension is one of the commonest non-communicable diseases in India, with an overall prevalence of 29.8% among the adult population, and a higher prevalence in urban areas (33.8% vs. 27.6%)
according to recent estimates.
Awareness of hypertension in India is low while appropriate treatment and control among those with hypertension is even lower: Hypertension is a chronic, persistent, largely asymptomatic disease. A majority of the patients with hypertension in India are unaware of their condition. This is because of low levels of awareness and the lack of screening for hypertension in adults-either as a systematic programme or as an opportunistic exercise during visits to healthcare providers.
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
... is the central focus of Sustainable Development Goal 3, “Ensure healthy lives and promote well-being for all
at all ages”. It is also relevant to all the Sustainable Development Goals. Understanding the significance of the
role of health is a prerequisite for successful collective action on the social, economic and environmental
determinants of health
DHS Analytical Studies No. 51
Child Health, Family Planning, Geographic Information, HIV, Malaria, Maternal Health
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of maternal and child health services. As part of these efforts, ...
The number of confirmed COVID-19 cases detected and reported in each country is influenced by
many factors including limited access and/or utilization of healthcare ... COVID-19 testing, limited
surveillance, lack of knowledge amongst the population about when to seek testing, an asymptomatic presentation, and other unknown issues. This is true in all countries of the world, and not Africa specific, however there are factors unique to Africa which may also affect the way the virus behaves there. COVID-19 prevalence data are critical for planning effective mitigation strategies and understandingthe true impact of the disease and relevant intervention measures in Africa, which might be quite different from regions with a different population age distribution or risk factor profile.
Report of the Joint World Health Organization–Brien Holden Vision Institute Global Scientific Meeting on Myopia | University of New South Wales, Sydney, Australia 16–18 March 2015
Report of a WHO technical consultation meeting
Ouagadougou, Burkina Faso
Inerim Guidance. These guidelines have been developed in recognition that infection with Zika virus may present a risk to blood safety, and in consideration of the declaration on 1 February 2016 by the WHO Director-General of a Public Health Emergen...
